article thumbnail

Genetic biomarkers could personalise therapy for TNBC

Drug Discovery World

Triple negative cancers are not driven by any of the three molecules that can be blocked by targeted hormone receptor drugs – the HER2 protein and two hormone receptors for oestrogen and progesterone – and so current treatment options are limited.

article thumbnail

My Hemochromatosis cb vsl | Blue Heron Health News

The Pharma Data

You possibly know that to have HCT you need an ‘HCT gene’ from your mom and another from your dad. But, as your doctor will have explained, lots of people have both these genes. It asks the question, ‘What is it that makes the ‘HCT gene’ devastate some lives – yet be completely harmless to others?’. They’d beaten HCT.